<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00962078</url>
  </required_header>
  <id_info>
    <org_study_id>PRÄ-LTX-08022</org_study_id>
    <secondary_id>Ethikkommission</secondary_id>
    <secondary_id>Landesärztekammer Bayern</secondary_id>
    <secondary_id>Nr. 08022</secondary_id>
    <nct_id>NCT00962078</nct_id>
  </id_info>
  <brief_title>Pulmonary Rehabilitation in Patients Before Lung Transplantation (LTx)</brief_title>
  <official_title>Effects of a Complex Pulmonary Rehabilitation Program on Patients With End Stage Lung Diseases Undergoing Evaluation for Lung Transplantation (Pre-LTx)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schön Klinik Berchtesgadener Land</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schön Klinik Berchtesgadener Land</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of a complex pulmonary rehabilitation
      program on mobility measured by 6 minute walking distance (6MWD) and physical activity,
      measured via Dynaport and Actibelt Aktivitätsmonitor, dyspnoea (VAS), quality of life (HRQL
      (SF36, EuroQul)), anxiety and depression (HADS)and PaCO2-behavior under physical activity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of a Multimodal Pulmonary Rehabilitation Program on 6 Minute Walking Distance (6MWD)</measure>
    <time_frame>value at day 21 minus value at day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnoea During Exercise Measured on the Borg Scale</measure>
    <time_frame>mean values from day 1 to day 21</time_frame>
    <description>The Borg scale is a numeric scale that ranges from 0 to 10 points to rate dyspnea.
The scale is like follows:
0 Nothing at all
Very slight
Slight
Moderate
Somewhat severe
Severe
7 Very severe 8 9 Very, very severe (almost maximal) 10 Maximal</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>COPD</condition>
  <condition>Pre-Lung-Transplantation</condition>
  <condition>Hypercapnia</condition>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>interval training in lung transplant candidates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous Training</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>continuous training in lung transplant candidates</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>continuous endurance training</intervention_name>
    <description>at 60 percent of peak Watt</description>
    <arm_group_label>Continuous Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interval training</intervention_name>
    <description>at 100 percent of peak Watt</description>
    <arm_group_label>interval training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pre-LTx (listed for lung-transplantation or currently undergoing evaluation)

          -  COPD Stadium IV GOLD

          -  α-1-Antitrypsin-deficiency-Emphysema

          -  respiratory Insufficiency

          -  oxygen therapy (LTOT)

        Exclusion Criteria:

          -  serious Exacerbation (Symptoms longer than three days, change of therapy, e.i.
             antibiotics, steroids) during the last four weeks before rehabilitation

          -  clinical signs of manifest heart insufficiency

          -  acute coronar syndrome

          -  left heart insufficiency(EF &lt; 40%)

          -  missing Compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Kenn, Dr.med.</last_name>
    <role>Study Director</role>
    <affiliation>Klinikum Berchtesgadener Land, Schön-Kliniken</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Berchtesgadener Land</name>
      <address>
        <city>Schönau am Königssee</city>
        <zip>83471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 27, 2009</study_first_submitted>
  <study_first_submitted_qc>August 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2009</study_first_posted>
  <results_first_submitted>March 6, 2019</results_first_submitted>
  <results_first_submitted_qc>August 21, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 23, 2019</results_first_posted>
  <last_update_submitted>August 21, 2019</last_update_submitted>
  <last_update_submitted_qc>August 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Schön Klinik Berchtesgadener Land</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Pre-Lung-Transplantation</keyword>
  <keyword>Intervall versus continuous training</keyword>
  <keyword>6 MWD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Interval Training</title>
          <description>interval training in lung transplant candidates
interval training: at 100 percent of peak Watt</description>
        </group>
        <group group_id="P2">
          <title>Continuous Training</title>
          <description>continuous training in lung transplant candidates
continuous endurance training: at 60 percent of peak Watt</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Interval Training</title>
          <description>interval training in lung transplant candidates
interval training: at 100 percent of peak Watt</description>
        </group>
        <group group_id="B2">
          <title>Continuous Training</title>
          <description>continuous training in lung transplant candidates
continuous endurance training: at 60 percent of peak Watt</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="71"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="6"/>
                    <measurement group_id="B2" value="55" spread="7"/>
                    <measurement group_id="B3" value="54" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FEV1%</title>
          <units>% predicted</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="8"/>
                    <measurement group_id="B2" value="27" spread="7"/>
                    <measurement group_id="B3" value="25" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effects of a Multimodal Pulmonary Rehabilitation Program on 6 Minute Walking Distance (6MWD)</title>
        <time_frame>value at day 21 minus value at day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Interval Training</title>
            <description>interval training in lung transplant candidates
interval training: at 100 percent of peak Watt</description>
          </group>
          <group group_id="O2">
            <title>Continuous Training</title>
            <description>continuous training in lung transplant candidates
continuous endurance training: at 60 percent of peak Watt</description>
          </group>
        </group_list>
        <measure>
          <title>Effects of a Multimodal Pulmonary Rehabilitation Program on 6 Minute Walking Distance (6MWD)</title>
          <units>meter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" spread="29"/>
                    <measurement group_id="O2" value="36" spread="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dyspnoea During Exercise Measured on the Borg Scale</title>
        <description>The Borg scale is a numeric scale that ranges from 0 to 10 points to rate dyspnea.
The scale is like follows:
0 Nothing at all
Very slight
Slight
Moderate
Somewhat severe
Severe
7 Very severe 8 9 Very, very severe (almost maximal) 10 Maximal</description>
        <time_frame>mean values from day 1 to day 21</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Interval Training</title>
            <description>interval training in lung transplant candidates
interval training: at 100 percent of peak Watt</description>
          </group>
          <group group_id="O2">
            <title>Continuous Training</title>
            <description>continuous training in lung transplant candidates
continuous endurance training: at 60 percent of peak Watt</description>
          </group>
        </group_list>
        <measure>
          <title>Dyspnoea During Exercise Measured on the Borg Scale</title>
          <description>The Borg scale is a numeric scale that ranges from 0 to 10 points to rate dyspnea.
The scale is like follows:
0 Nothing at all
Very slight
Slight
Moderate
Somewhat severe
Severe
7 Very severe 8 9 Very, very severe (almost maximal) 10 Maximal</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="1.6"/>
                    <measurement group_id="O2" value="7.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Interval Training</title>
          <description>interval training in lung transplant candidates
interval training: at 100 percent of peak Watt</description>
        </group>
        <group group_id="E2">
          <title>Continuous Training</title>
          <description>continuous training in lung transplant candidates
continuous endurance training: at 60 percent of peak Watt</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Rainer Gloeckl</name_or_title>
      <organization>Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany</organization>
      <phone>+49 8652 931630</phone>
      <email>rgloeckl@schoen-klinik.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

